SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-000149
Filing Date
2019-01-07
Accepted
2019-01-07 16:37:30
Documents
3
Period of Report
2019-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kxbmssupplyagreement.htm 8-K 35031
2 EXHIBIT 99.1 pressrelease-bmssupplyagre.htm EX-99.1 13850
3 miratilogopurplev2a04.jpg GRAPHIC 17052
  Complete submission text file 0001628280-19-000149.txt   73306
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 19513753
SIC: 2834 Pharmaceutical Preparations